FDA.reportPublic FDA data

Arnuity Ellipta 200 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT

RxCUI
1547672
RxNorm name
Arnuity Ellipta 200 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT
Display name
Arnuity Ellipta 200 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT
Full name
Arnuity Ellipta 200 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
50f193ee-1691-486d-9370-a664df63695cArnuity Ellipta 200 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUATSY17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018
50f193ee-1691-486d-9370-a664df63695c30 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler [Arnuity]SBD17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018
50f193ee-1691-486d-9370-a664df63695cARNUITY ELLIPTA 200 MCG/INHAL Dry Powder Inhaler, 30 BlistersPSN17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018